E. A. Ertel

发表

Effects of the T-type Ca(2+) channel blocker mibefradil on repolarization of guinea pig, rabbit, dog, monkey, and human cardiac tissue.

A. Bénardeau, L. Hondeghem, J. Weissenburger, 2000, The Journal of pharmacology and experimental therapeutics.

Discovery and main pharmacological properties of mibefradil (Ro 40‐5967), the first selective T‐type calcium channel blocker

S. Ertel, J. Clozel, E. A. Ertel, 1997, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

Voltage-gated T-type Ca2+ channels and heart failure.

S. Ertel, J. Clozel, E. A. Ertel, 1999, Proceedings of the Association of American Physicians.

Inhibitory action of mibefradil on calcium signaling and aldosterone synthesis in bovine adrenal glomerulosa cells.

M. Rossier, M. Vallotton, A. Capponi, 1998, The Journal of pharmacology and experimental therapeutics.

Type III omega-agatoxins: a family of probes for similar binding sites on L- and N-type calcium channels.

P. Griffin, M. Adams, V. Warren, 1994, Biochemistry.

Contractions of Human-iPSC-derived Cardiomyocyte Syncytia Measured with a Ca-sensitive Fluorescent Dye in Temperature-controlled 384-well Plates

E. A. Ertel, Camille Forny, Romain Sube, 2018, Journal of visualized experiments : JoVE.

Voltage-gated calcium currents have two opposing effects on the secretion of aldosterone.

P. Barrett, C. Cohen, E. A. Ertel, 1995, The American journal of physiology.

Synthesis and Characterization of Tetrahydropyran-Based Bacterial Topoisomerase Inhibitors with Antibacterial Activity against Gram-Negative Bacteria.

D. Ritz, H. Locher, P. Seiler, 2017, Journal of medicinal chemistry.

Discovery and Optimization of Isoquinoline Ethyl Ureas as Antibacterial Agents.

L. Prade, D. Ritz, P. Seiler, 2017, Journal of medicinal chemistry.

Discovery of a Potent, Selective T-type Calcium Channel Blocker as a Drug Candidate for the Treatment of Generalized Epilepsies.

R. de Kanter, Simon Stamm, E. A. Ertel, 2017, Journal of medicinal chemistry.

Calcium channel blockers and calcium channels

T. Godfraind, E. A. Ertel, 2004 .

Nodulisporic acid opens insect glutamate-gated chloride channels: identification of a new high affinity modulator.

D. Schmatz, J. Schaeffer, V. Warren, 2000, Biochemistry.

Preparation, Antiepileptic Activity, and Cardiovascular Safety of Dihydropyrazoles as Brain-Penetrant T-Type Calcium Channel Blockers.

J. Mosbacher, E. A. Ertel, O. Bezençon, 2016, Journal of medicinal chemistry.

Nomenclature of Voltage-Gated Calcium Channels

R. Tsien, W. Catterall, K. Campbell, 2000, Neuron.

Discovery of Clinical Candidate ACT-777991, a Potent CXCR3 Antagonist for Antigen-Driven and Inflammatory Pathologies.

M. Martinic, E. Meyer, S. Froidevaux, 2023, Journal of medicinal chemistry.

T-Type Ca2+ Channels and Pharmacological Blockade: Potential Pathophysiological Relevance

S. Ertel, J. Clozel, E. A. Ertel, 1997, Cardiovascular Drugs and Therapy.

Pharmacology of Cav3 (T-Type) Channels

E. A. Ertel, 2004 .

Low-voltage-activated T-type Ca2+ channels.

S. Ertel, E. A. Ertel, 1997, Trends in pharmacological sciences.

Novel tetrahydropyran-based bacterial topoisomerase inhibitors with potent anti-gram positive activity and improved safety profile.

D. Ritz, H. Locher, P. Seiler, 2015, Journal of medicinal chemistry.

Discovery and evaluation of Cav3.2-selective T-type calcium channel blockers.

E. A. Ertel, O. Bezençon, L. Remeň, 2017, Bioorganic & medicinal chemistry letters.

Discovery and evaluation of Cav3.1-selective T-type calcium channel blockers.

E. A. Ertel, O. Bezençon, L. Remeň, 2017, Bioorganic & medicinal chemistry letters.

Isolation of myocardial L-type calcium channel gating currents with the spider toxin omega-Aga-IIIA

M. D. Leibowitz, C. Cohen, E. A. Ertel, 1994, The Journal of general physiology.

Pharmacological properties of Cav3.2, a low voltage-activated Ca2+ channel cloned from human heart

A. Bénardeau, E. A. Ertel, L. Perchenet, 2000, Naunyn-Schmiedeberg's Archives of Pharmacology.

Modulation of guanylate cyclase and phosphodiesterase by monovalent cations and nucleoside triphosphates in light-sensitive excised patches of rod outer segments

E. A. Ertel, 1994, Pflügers Archiv.

Excised patches of plasma membrane from vertebrate rod outer segments retain a functional phototransduction enzymatic cascade.

E. A. Ertel, 1990, Proceedings of the National Academy of Sciences of the United States of America.

Evaluation of the Rabbit Purkinje Fibre Assay as an in vitro Tool for Assessing the Risk of Drug-Induced Torsades de Pointes in Humans

Björn Wagner, Isabelle Parrilla, Icilio Cavero, 2006, Drug safety.

Lucerastat, an iminosugar for substrate reduction therapy in Fabry disease: preclinical evidence

D. Priestman, F. Platt, M. Iglarz, 2017 .

Voltage‐dependent interactions: The influence and significance of membrane potential on drug‐receptor interactions

C. Cohen, E. A. Ertel, 1994 .

Cardiomyocytes Derived from Human Induced Pluripotent Stem Cells: An In-Vitro Model to Predict Cardiac Effects of Drugs

E. A. Ertel, Romain Sube, Eric A. Ertel, 2017 .

Isolation of Myocardial L-type Calcium Channel Gating Currents with the Spider Toxin 0 -aga-iiia

E. A. Ertel, Charles J. Cohen, Mark D. Leibowitz, 2022 .